Showing results (31-40 of 130) with videos related to
Sort By:
Pageof 13
Expert Opinion on Biological Therapy|March 22, 2006
Gene therapy in combination with tissue engineering to treat epidermolysis bullosaStefano Ferrari, Graziella Pellegrini, Tatsuya Matsui, et al.Reviews on Recent Clinical Trials|May 14, 2008
Towards a gene therapy clinical trial for epidermolysis bullosaStefano Ferrari, Graziella Pellegrini, Tatsuya Matsui, et al.Molecular Therapy. Nucleic Acids|September 10, 2018
Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed RepairAraksya Izmiryan, Clarisse Ganier, Matteo Bovolenta, et al.The Journal of Clinical Investigation|August 3, 2007
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapyAlessandro Aiuti, Barbara Cassani, Grazia Andolfi, et al.Plos One|December 14, 2011
The GATA1-HS2 enhancer allows persistent and position-independent expression of a β-globin transgeneAnnarita Miccio, Valentina Poletti, Francesca Tiboni, et al.Human Gene Therapy|May 27, 2005
Competitive engraftment of hematopoietic stem cells genetically modified with a truncated erythropoietin receptorFabrizia Urbinati, Francesco Lotti, Giulia Facchini, et al.The Journal of Cell Biology|June 15, 2007
C/EBPdelta regulates cell cycle and self-renewal of human limbal stem cellsVanessa Barbaro, Anna Testa, Enzo Di Iorio, et al.Stem Cells (Dayton, Ohio)|January 15, 2008
Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cellsSimona Salati, Roberta Zini, Elisa Bianchi, et al.Journal of Virology|March 22, 2002
Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacementFrancesco Lotti, Emilio Menguzzato, Claudia Rossi, et al.Carcinogenesis|December 6, 2008
PPARdelta is a ligand-dependent negative regulator of vitamin D3-induced monocyte differentiationAthina Lymboussaki, Claudia Gemelli, Anna Testa, et al.Pageof 13